2,775
Views
17
CrossRef citations to date
0
Altmetric
Editorial

Therapeutic targeting of isocitrate dehydrogenase mutant AML

&
Pages 525-530 | Received 18 Jan 2017, Accepted 06 Apr 2017, Published online: 19 Apr 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Laura C. Michaelis, Heidi D. Klepin & Roland B. Walter. (2018) Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia. Expert Opinion on Pharmacotherapy 19:8, pages 865-882.
Read now

Articles from other publishers (16)

Emre LEVENTOGLU, Gurses SAHIN, Sule YESIL, Ceyhun BOZKURT, Nazmiye YUKSEK, Ali FETTAH, Sule TOPRAK, Burcak KURUCU BILGIN, Emre CAPKINOGLU, Nilgun EROGLU, Sibel AKPINAR TEKGUNDUZ & Ayse Ulya ERTEM. (2023) Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients. Medeniyet Medical Journal 38:2, pages 102-110.
Crossref
Michihiro Kurimoto, Yumi Rockenbach, Akira Kato & Atsushi Natsume. (2023) Prediction of Tumor Development and Urine-Based Liquid Biopsy for Molecule-Targeted Therapy of Gliomas. Genes 14:6, pages 1201.
Crossref
Atsushi Natsume, Yoshiki Arakawa, Yoshitaka Narita, Kazuhiko Sugiyama, Nobuhiro Hata, Yoshihiro Muragaki, Naoki Shinojima, Toshihiro Kumabe, Ryuta Saito, Kazuya Motomura, Yohei Mineharu, Yasuji Miyakita, Fumiyuki Yamasaki, Yuko Matsushita, Koichi Ichimura, Kazumi Ito, Masaya Tachibana, Yasuyuki Kakurai, Naoko Okamoto, Takashi Asahi, Soichiro Nishijima, Tomoyuki Yamaguchi, Hiroshi Tsubouchi, Hideo Nakamura & Ryo Nishikawa. (2023) The first-in-human phase I study of a brain-penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas. Neuro-Oncology 25:2, pages 326-336.
Crossref
Lijiao Wang, Rong Li, Chen Song, Yanli Chen, Haiyue Long & Lingling Yang. (2021) Small-Molecule Anti-Cancer Drugs From 2016 to 2020: Synthesis and Clinical Application. Natural Product Communications 16:9, pages 1934578X2110403.
Crossref
Zhiqiang Wang, Zhibo Zhang, Yong Li, Li Sun, Dezhen Peng, Danyu Du, Xian Zhang, Luwei Han, Liwen Zhao, Ligong Lu, Hongzhi Du, Shengtao Yuan & Meixiao Zhan. (2021) Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China. Acta Pharmaceutica Sinica B 11:6, pages 1526-1540.
Crossref
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, Jacob C. DeForest, Peter D. Morse, Subham Mahapatra & Christopher J. O’Donnell. (2020) Synthetic Approaches to New Drugs Approved during 2018. Journal of Medicinal Chemistry 63:19, pages 10652-10704.
Crossref
Cassandra Bruce-Brand & Dhirendra Govender. (2020) Gene of the month: IDH1 . Journal of Clinical Pathology 73:10, pages 611-615.
Crossref
Carmelo Gurnari, Maria Teresa Voso, Jaroslaw P. Maciejewski & Valeria Visconte. (2020) From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia. Cancers 12:2, pages 357.
Crossref
Rosario Avolio, Danilo Swann Matassa, Daniela Criscuolo, Matteo Landriscina & Franca Esposito. (2020) Modulation of Mitochondrial Metabolic Reprogramming and Oxidative Stress to Overcome Chemoresistance in Cancer. Biomolecules 10:1, pages 135.
Crossref
Georg Karpel-Massler, Trang T. T. Nguyen, Enyuan Shang & Markus D. Siegelin. (2019) Novel IDH1-Targeted Glioma Therapies. CNS Drugs 33:12, pages 1155-1166.
Crossref
Saveg Yadav, Shrish Kumar Pandey, Yugal Goel, Mithlesh Kumar Temre & Sukh Mahendra Singh. (2019) Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate. Frontiers in Pharmacology 10.
Crossref
Carmelo Gurnari, Giulia Falconi, Eleonora De Bellis, Maria Teresa Voso & Emiliano Fabiani. (2019) The Role of Forkhead Box Proteins in Acute Myeloid Leukemia. Cancers 11:6, pages 865.
Crossref
Tsila Zuckerman & Jacob M. Rowe. (2019) Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemia. Current Opinion in Hematology 26:2, pages 51-57.
Crossref
. (2019) Immunometabolic Regulation of Anti-Tumor T-Cell Responses by the Oncometabolite D-2-Hydroxyglutarate. Immunometabolism.
Crossref
Eric Goethe, Bing Z. Carter, Ganesh Rao & Naveen Pemmaraju. (2017) Glioblastoma and acute myeloid leukemia: malignancies with striking similarities. Journal of Neuro-Oncology 136:2, pages 223-231.
Crossref
Na Wang, Fei Wang, Ningning Shan, Xiaohui Sui & Hongzhi Xu. (2017) IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes. Acta Haematologica 138:3, pages 143-151.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.